Winton Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,755
| Closed | -$409K | – | 705 |
|
|
2024
Q1 | $409K | Buy |
+8,755
| New | +$409K | 0.03% | 495 |
|
|
2023
Q2 | – | Sell |
-8,518
| Closed | -$342K | – | 1057 |
|
|
2023
Q1 | $342K | Buy |
+8,518
| New | +$342K | 0.02% | 788 |
|
|
2022
Q3 | – | Sell |
-5,678
| Closed | -$339K | – | 1064 |
|
|
2022
Q2 | $339K | Buy |
+5,678
| New | +$339K | 0.02% | 780 |
|